Loading…
Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery
The brush border membrane of intestinal mucosal cells contains a peptide carrier system with rather broad substrate specificity and various endo- and exopeptidase activities. Small peptide (di-/tripeptide)-type drugs with or without an N-terminal alpha-amino group, including beta-lactam antibiotics...
Saved in:
Published in: | Pharmaceutical research 1992-08, Vol.9 (8), p.969-978 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c368t-c2c6450bd253dbfe5e0cd88419b840a5e2ca1adcfae59dee83d4a9400ccb251e3 |
---|---|
cites | |
container_end_page | 978 |
container_issue | 8 |
container_start_page | 969 |
container_title | Pharmaceutical research |
container_volume | 9 |
creator | Bai, J. P. Amidon, G. L. |
description | The brush border membrane of intestinal mucosal cells contains a peptide carrier system with rather broad substrate specificity and various endo- and exopeptidase activities. Small peptide (di-/tripeptide)-type drugs with or without an N-terminal alpha-amino group, including beta-lactam antibiotics and angiotensin-converting enzyme (ACE) inhibitors, are transported by the peptide transporter. Polypeptide drugs are hydrolyzed by brush border membrane proteolytic enzymes to di-/tripeptides and amino acids. Therefore, while the intestinal brush border membrane has a carrier system facilitating the absorption of di-/tripeptide drugs, it is a major barrier limiting oral availability of polypeptide drugs. In this paper, the specificity of peptide transport and metabolism in the intestinal brush border membrane is reviewed. |
doi_str_mv | 10.1023/a:1015885823793 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73250026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73250026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-c2c6450bd253dbfe5e0cd88419b840a5e2ca1adcfae59dee83d4a9400ccb251e3</originalsourceid><addsrcrecordid>eNpNkU2LFDEQhoO4rOPo2YtCDuKt18rXdHpvy-IXLOxBBW9NdVItkXSnTdILA_54e9hBPNXhfXiLeoqxVwKuBEj1Hq8FCGOtsVK1nXrCdsK0qulA_3jKdtBK3dhWi2fseSm_AMCKTl-yS6GhU7bdsT9fa15dXTNGXhZyYQwu1CNPI59WlwrGxlGMvGacy5Jy5Th7PlHFIcVQphO40FKDJ-7z-rNc8zAtMTisIc18TJmnU_f_DPcUwwPl4wt2MWIs9PI89-z7xw_fbj83d_efvtze3DVOHWxtnHQHbWDw0ig_jGQInLdWi26wGtCQdCjQuxHJdJ7IKq-x0wDODdIIUnv27rF3yen3SqX2Uyins3CmtJa-VdIAyMMGvjmD6zCR75ccJszH_qxry9-ecywO47hJcaH8w8ymXm9f2bPXj9iMBfu55tJLgG0FwEFp9RdUoIVf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73250026</pqid></control><display><type>article</type><title>Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery</title><source>Springer Nature - Connect here FIRST to enable access</source><creator>Bai, J. P. ; Amidon, G. L.</creator><creatorcontrib>Bai, J. P. ; Amidon, G. L.</creatorcontrib><description>The brush border membrane of intestinal mucosal cells contains a peptide carrier system with rather broad substrate specificity and various endo- and exopeptidase activities. Small peptide (di-/tripeptide)-type drugs with or without an N-terminal alpha-amino group, including beta-lactam antibiotics and angiotensin-converting enzyme (ACE) inhibitors, are transported by the peptide transporter. Polypeptide drugs are hydrolyzed by brush border membrane proteolytic enzymes to di-/tripeptides and amino acids. Therefore, while the intestinal brush border membrane has a carrier system facilitating the absorption of di-/tripeptide drugs, it is a major barrier limiting oral availability of polypeptide drugs. In this paper, the specificity of peptide transport and metabolism in the intestinal brush border membrane is reviewed.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1023/a:1015885823793</identifier><identifier>PMID: 1409387</identifier><identifier>CODEN: PHREEB</identifier><language>eng</language><publisher>Legacy CDMS: Springer</publisher><subject>Administration, Oral ; Amino Acid Sequence ; Angiotensin-Converting Enzyme Inhibitors - administration & dosage ; Angiotensin-Converting Enzyme Inhibitors - chemistry ; Angiotensin-Converting Enzyme Inhibitors - metabolism ; Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics ; Animals ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - metabolism ; Anti-Bacterial Agents - pharmacokinetics ; Biological and medical sciences ; Biological Transport ; Endopeptidases - metabolism ; Exopeptidases ; General pharmacology ; Humans ; Hydrolysis ; Intestinal Mucosa - cytology ; Intestinal Mucosa - metabolism ; Lactams ; Life Sciences (General) ; Medical sciences ; Microvilli - metabolism ; Molecular Sequence Data ; Peptide Hydrolases - metabolism ; Peptides - administration & dosage ; Peptides - chemistry ; Peptides - metabolism ; Peptides - pharmacokinetics ; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions ; Pharmacology. Drug treatments ; Prodrugs - metabolism ; Space life sciences</subject><ispartof>Pharmaceutical research, 1992-08, Vol.9 (8), p.969-978</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-c2c6450bd253dbfe5e0cd88419b840a5e2ca1adcfae59dee83d4a9400ccb251e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5573402$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1409387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bai, J. P.</creatorcontrib><creatorcontrib>Amidon, G. L.</creatorcontrib><title>Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><description>The brush border membrane of intestinal mucosal cells contains a peptide carrier system with rather broad substrate specificity and various endo- and exopeptidase activities. Small peptide (di-/tripeptide)-type drugs with or without an N-terminal alpha-amino group, including beta-lactam antibiotics and angiotensin-converting enzyme (ACE) inhibitors, are transported by the peptide transporter. Polypeptide drugs are hydrolyzed by brush border membrane proteolytic enzymes to di-/tripeptides and amino acids. Therefore, while the intestinal brush border membrane has a carrier system facilitating the absorption of di-/tripeptide drugs, it is a major barrier limiting oral availability of polypeptide drugs. In this paper, the specificity of peptide transport and metabolism in the intestinal brush border membrane is reviewed.</description><subject>Administration, Oral</subject><subject>Amino Acid Sequence</subject><subject>Angiotensin-Converting Enzyme Inhibitors - administration & dosage</subject><subject>Angiotensin-Converting Enzyme Inhibitors - chemistry</subject><subject>Angiotensin-Converting Enzyme Inhibitors - metabolism</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - metabolism</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Biological Transport</subject><subject>Endopeptidases - metabolism</subject><subject>Exopeptidases</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Hydrolysis</subject><subject>Intestinal Mucosa - cytology</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Lactams</subject><subject>Life Sciences (General)</subject><subject>Medical sciences</subject><subject>Microvilli - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Peptide Hydrolases - metabolism</subject><subject>Peptides - administration & dosage</subject><subject>Peptides - chemistry</subject><subject>Peptides - metabolism</subject><subject>Peptides - pharmacokinetics</subject><subject>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</subject><subject>Pharmacology. Drug treatments</subject><subject>Prodrugs - metabolism</subject><subject>Space life sciences</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNpNkU2LFDEQhoO4rOPo2YtCDuKt18rXdHpvy-IXLOxBBW9NdVItkXSnTdILA_54e9hBPNXhfXiLeoqxVwKuBEj1Hq8FCGOtsVK1nXrCdsK0qulA_3jKdtBK3dhWi2fseSm_AMCKTl-yS6GhU7bdsT9fa15dXTNGXhZyYQwu1CNPI59WlwrGxlGMvGacy5Jy5Th7PlHFIcVQphO40FKDJ-7z-rNc8zAtMTisIc18TJmnU_f_DPcUwwPl4wt2MWIs9PI89-z7xw_fbj83d_efvtze3DVOHWxtnHQHbWDw0ig_jGQInLdWi26wGtCQdCjQuxHJdJ7IKq-x0wDODdIIUnv27rF3yen3SqX2Uyins3CmtJa-VdIAyMMGvjmD6zCR75ccJszH_qxry9-ecywO47hJcaH8w8ymXm9f2bPXj9iMBfu55tJLgG0FwEFp9RdUoIVf</recordid><startdate>19920801</startdate><enddate>19920801</enddate><creator>Bai, J. P.</creator><creator>Amidon, G. L.</creator><general>Springer</general><scope>CYE</scope><scope>CYI</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19920801</creationdate><title>Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery</title><author>Bai, J. P. ; Amidon, G. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-c2c6450bd253dbfe5e0cd88419b840a5e2ca1adcfae59dee83d4a9400ccb251e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Administration, Oral</topic><topic>Amino Acid Sequence</topic><topic>Angiotensin-Converting Enzyme Inhibitors - administration & dosage</topic><topic>Angiotensin-Converting Enzyme Inhibitors - chemistry</topic><topic>Angiotensin-Converting Enzyme Inhibitors - metabolism</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - metabolism</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Biological Transport</topic><topic>Endopeptidases - metabolism</topic><topic>Exopeptidases</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Hydrolysis</topic><topic>Intestinal Mucosa - cytology</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Lactams</topic><topic>Life Sciences (General)</topic><topic>Medical sciences</topic><topic>Microvilli - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Peptide Hydrolases - metabolism</topic><topic>Peptides - administration & dosage</topic><topic>Peptides - chemistry</topic><topic>Peptides - metabolism</topic><topic>Peptides - pharmacokinetics</topic><topic>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</topic><topic>Pharmacology. Drug treatments</topic><topic>Prodrugs - metabolism</topic><topic>Space life sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bai, J. P.</creatorcontrib><creatorcontrib>Amidon, G. L.</creatorcontrib><collection>NASA Scientific and Technical Information</collection><collection>NASA Technical Reports Server</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bai, J. P.</au><au>Amidon, G. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery</atitle><jtitle>Pharmaceutical research</jtitle><addtitle>Pharm Res</addtitle><date>1992-08-01</date><risdate>1992</risdate><volume>9</volume><issue>8</issue><spage>969</spage><epage>978</epage><pages>969-978</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><coden>PHREEB</coden><abstract>The brush border membrane of intestinal mucosal cells contains a peptide carrier system with rather broad substrate specificity and various endo- and exopeptidase activities. Small peptide (di-/tripeptide)-type drugs with or without an N-terminal alpha-amino group, including beta-lactam antibiotics and angiotensin-converting enzyme (ACE) inhibitors, are transported by the peptide transporter. Polypeptide drugs are hydrolyzed by brush border membrane proteolytic enzymes to di-/tripeptides and amino acids. Therefore, while the intestinal brush border membrane has a carrier system facilitating the absorption of di-/tripeptide drugs, it is a major barrier limiting oral availability of polypeptide drugs. In this paper, the specificity of peptide transport and metabolism in the intestinal brush border membrane is reviewed.</abstract><cop>Legacy CDMS</cop><pub>Springer</pub><pmid>1409387</pmid><doi>10.1023/a:1015885823793</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 1992-08, Vol.9 (8), p.969-978 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_proquest_miscellaneous_73250026 |
source | Springer Nature - Connect here FIRST to enable access |
subjects | Administration, Oral Amino Acid Sequence Angiotensin-Converting Enzyme Inhibitors - administration & dosage Angiotensin-Converting Enzyme Inhibitors - chemistry Angiotensin-Converting Enzyme Inhibitors - metabolism Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - metabolism Anti-Bacterial Agents - pharmacokinetics Biological and medical sciences Biological Transport Endopeptidases - metabolism Exopeptidases General pharmacology Humans Hydrolysis Intestinal Mucosa - cytology Intestinal Mucosa - metabolism Lactams Life Sciences (General) Medical sciences Microvilli - metabolism Molecular Sequence Data Peptide Hydrolases - metabolism Peptides - administration & dosage Peptides - chemistry Peptides - metabolism Peptides - pharmacokinetics Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions Pharmacology. Drug treatments Prodrugs - metabolism Space life sciences |
title | Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T10%3A33%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20specificity%20of%20mucosal-cell%20transport%20and%20metabolism%20of%20peptide%20drugs:%20implication%20for%20oral%20peptide%20drug%20delivery&rft.jtitle=Pharmaceutical%20research&rft.au=Bai,%20J.%20P.&rft.date=1992-08-01&rft.volume=9&rft.issue=8&rft.spage=969&rft.epage=978&rft.pages=969-978&rft.issn=0724-8741&rft.eissn=1573-904X&rft.coden=PHREEB&rft_id=info:doi/10.1023/a:1015885823793&rft_dat=%3Cproquest_pubme%3E73250026%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c368t-c2c6450bd253dbfe5e0cd88419b840a5e2ca1adcfae59dee83d4a9400ccb251e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73250026&rft_id=info:pmid/1409387&rfr_iscdi=true |